eGFP/Firefly Luciferase MIA PaCa-2 Cell Line
Recombinant MIA PaCa-2 cells expressing firefly luciferase and enhanced GFP (eGFP) driven by an EF1a promoter, generated by transduction with Firefly Luciferase-eGFP lentivirus (BPS Bioscience #78741).
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
Name | Ordering Information |
Thaw Medium 17 | BPS Bioscience #78767 |
Growth Medium 17A | BPS Bioscience #78768 |
The cell line has been screened to confirm the absence of Mycoplasma species.
MIA PaCa-2 is a human epithelial cell line derived from the pancreatic cancer tissue of a 65-year-old male. It is commonly used as a tumor model in pancreatic cancer research and therapy development. The genotyping of MIA PaCa-2 confirmed the presence of a homozygous missense mutation (G12C) in KRAS (K-Ras), a homozygous deletion encompassing exons 1, 2 and 3 of the CDKN2A/p16INK4A (cyclin-dependent kinase inhibitor 2A) gene and a homozygous missense mutation (R248W) in exon 7 of TP53 (tumor protein 53, or p53).